These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6444904)

  • 21. Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice.
    Sandberg JO; Andersson A; Eizirik DL; Sandler S
    Biochem Biophys Res Commun; 1994 Jul; 202(1):543-8. PubMed ID: 8037760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of ionizing radiation on the resistance of rat pancreatic beta cells to streptozotocin].
    Gatsko GG; Brilevskaia SI
    Radiobiologiia; 1993; 33(2):225-8. PubMed ID: 8502739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of syngenic pancreatic islets into rats with streptozotocin induced non insulin dependent diabetes mellitus.
    Tormo MA; Bailbé D; Serradas P; Saulnier C; Portha B; Campillo JE
    Adv Exp Med Biol; 1997; 426():441-5. PubMed ID: 9544304
    [No Abstract]   [Full Text] [Related]  

  • 24. Superoxide dismutase reduces islet microvascular injury induced by streptozotocin in the rat.
    Enghofer M; Usadel KH; Beck O; Kusterer K
    Am J Physiol; 1997 Aug; 273(2 Pt 1):E376-82. PubMed ID: 9277392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
    J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of 4,6-O-ethylidene glucose against the cytotoxicity of streptozotocin in pancreatic beta cells in vivo: indirect evidence for the presence of a glucose transporter in beta cells.
    Kawada J; Okita M; Nishida M; Yoshimura Y; Toyooka K; Kubota S
    J Endocrinol; 1987 Mar; 112(3):375-8. PubMed ID: 2951476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of alloxan action in isolated pancreatic islets by superoxide dismutase, catalase, and a metal chelator.
    Fischer LJ; Hamburger SA
    Diabetes; 1980 Mar; 29(3):213-6. PubMed ID: 6991324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic chloroquine treatment enhances insulin release in rats.
    Asamoah KA; Robb DA; Furman BL
    Diabetes Res Clin Pract; 1990 Jul; 9(3):273-8. PubMed ID: 2146103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptozotocin alters pancreatic beta-cell responsiveness to glucose within six hours of injection into rats.
    West E; Simon OR; Morrison EY
    West Indian Med J; 1996 Jun; 45(2):60-2. PubMed ID: 8772396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
    Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
    Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superoxide dismutase in low-dose-streptozocin-treated mice. A dynamic time-course study.
    Papaccio G; Latronico M; Frascatore S; Pisanti FA
    Int J Pancreatol; 1991; 10(3-4):253-60. PubMed ID: 1838564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant activity of chito-oligosaccharides on pancreatic islet cells in streptozotocin-induced diabetes in rats.
    Yuan WP; Liu B; Liu CH; Wang XJ; Zhang MS; Meng XM; Xia XK
    World J Gastroenterol; 2009 Mar; 15(11):1339-45. PubMed ID: 19294763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete protection from low-dose streptozotocin-induced diabetes in mice.
    Rossini AA; Williams RM; Appel MC; Like AA
    Nature; 1978 Nov; 276(5684):182-4. PubMed ID: 154064
    [No Abstract]   [Full Text] [Related]  

  • 38. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.
    Thaete LG; Crouch RK; Buse MG; Spicer SS
    Diabetologia; 1985 Sep; 28(9):677-82. PubMed ID: 3905479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terbutaline decreases the blood flow of the pancreatic islets but does not reduce the diabetogenic action of streptozotocin in the rat.
    Jansson L; Eizirik DL; Sandler S
    Eur J Pharmacol; 1989 Feb; 161(1):79-83. PubMed ID: 2656272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral studies in streptozotocin-induced pancreatic insulitis.
    Appel MC; Rossini AA; Williams RM; Like AA
    Diabetologia; 1978 Oct; 15(4):327-36. PubMed ID: 213334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.